Evidence map›Paper›PMID 41809878›Full record

ArticleWorld journal of gastroenterology2026

Targeting

Sheng Xu, Zheng Zhu, Hui-Ming Zhang, Yue-Ting Xu, Pei-Hong Shi, Yang Zheng, Yi-Tong Chen, Guang-Rong Lu, Bin-Jiao Zheng

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sheng XuDepartment of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Zheng ZhuThe Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Hui-Ming ZhangThe Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Yue-Ting XuThe Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Pei-Hong ShiThe Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Yang ZhengThe Second School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Yi-Tong ChenThe First School of Medicine, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Guang-Rong LuDepartment of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Bin-Jiao ZhengKey Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crohn's disease (CD) activity and postoperative recurrence significantly affect patients' quality of life, highlighting the need for new treatment and prevention strategies. We read with interest Boronat-Toscano

Indexed as

Crohn DiseaseGastrointestinal MicrobiomeSuccinic AcidFecesHumansQuality of LifeRecurrenceSecondary PreventionSeverity of Illness IndexSuccinic AcidCrohn’s diseaseDialisterGut microbiotaInflammatory bowel diseasePostoperative recurrenceSuccinateTherapeutic targets

Identifiers

PMID41809878
PMCPMC12968552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.